Skip to Content

Notice

National Center for Complementary & Alternative Medicine; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to Section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the National Advisory Council for Complementary and Alternative Medicine (NACCAM).

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Advisory Council for Complementary and Alternative Medicine.

Date: May 8-9, 2000.

Open: May 8, 2000, 8:30 am to adjournment.

Agenda: The agenda includes the Director's Report and presentation of NCCAM's Draft Strategic Plan, Development of Trans-NIH Health Start Printed Page 21776Disparities, Public Comments, and other business of the Council. Closed: May 9, 2000, 8:30 am to adjournment. FP1-2>Agenda: To review and evaluate grant applications and/or proposals.

Place: NIH Neuroscience Office Building, 6001 Executive Boulevard, Conference Room C, Rockville, MD 20852.

Contact Person: Richard Nahin, Executive Secretary, National Center for Complementary and Alternative Medicine, National Institutes of Health, 9000 Rockville Pike, Room 5B36, Bethesda, MD 20892; 301-594-2013.

The public comments session is scheduled from 1:15 pm to 2:15 pm. Each speaker will be permitted 5 minutes for their presentation. Interested individuals and representatives of organizations are requested to notify Dr. Richard Nahin, National Center for Complementary and Alternative Medicine, NIH, 31 Center Drive, (MSC 2182), Building 31, Room 5B36, Bethesda, Maryland, 20892, 301-594-2013, Fax: 301-480-9500.

Letters of intent to present comments, along with a brief description of the organization represented, should be received no later than 5 pm on May 3, 2000. Only one representative of an organization may present oral comments.

Any person attending the meeting who does not request an opportunity to speak in advance of the meeting may be considered for oral presentation, if time permits, and at the discretion of the Chairperson. In addition, written comments may be submitted to Dr. Hahin at the address listed above up to ten calendar days (May 19, 2000) following the meeting.

Copies of the meeting agenda and the roster of members will be furnished upon request by Dr. Richard Nahin, Executive Secretary, NACCAM,National Institutes of Health, Building 31, Room 5B36, 31 Center Drive, Bethesda, MD 20892; (301) 594-2013, Fax 301-480-9500.

Start Signature

Dated: April 17, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy, NIH.

End Signature End Preamble

[FR Doc. 00-10170 Filed 4-21-00; 8:45 am]

BILLING CODE 4140-01-M